News

Scientists have successfully tested in animals a drug that, they say, may one day help block the withdrawal symptoms and cravings that incessantly coax people with alcoholism to drink. If eventually brought to market, it could help many around the world who suffer from alcoholism stay sober.

Researchers have characterized a new protein that is important to the genetic stability of our cells. It may be significant for the development of new drugs against genetically determined diseases like cancer, sterility and premature ageing.

A study reveals how a membrane protein within plant cells serves as a scaffold to organize three key enzymes involved in building the cell's exterior support.

Pinpoint stimulation of a cluster of nerve cells in the brains of mice encouraged timid responses to a perceived threat, whereas stimulation of an adjacent cluster induced boldness and courage.

A group of researchers have created CrowdFit, a platform for exercise planning that relies on crowdsourcing from nonexperts to create workout regimens guided by national exercise recommendations and tailored around user schedules and interests.

Scientists have potentially found a way to use chemical compounds to target and inhibit the growth of specific microbes in the gut associated with diseases without causing harm to other beneficial organisms.

UT Southwestern researchers today published in Nature atomic-scale blueprints of the most abundant class of brain nicotinic acetylcholine receptors. A structural understanding of the protein, found in neurons, could lead to new ways to treat nicotine addiction from smoking and vaping.

Researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer. Experiments in mice and with human cells showed that blocking this stress response with an experimental drug -- previously shown to enhance cognition and restore memory after brain damage in rodents -- causes treatment-resistant cancer cells to self-destruct while leaving normal cells unaffected.

Scientists at The Scripps Research Institute aim to improve flu and malaria vaccines with the support of a new $12 million grant from the Bill & Melinda Gates Foundation.

Peerwith, a company offering a peer-to-peer marketplace for science, have announced their blockchain-based payment token, PeerScienceCoin. Peerwith envision the currency as a solution to the complexity of micro-payments in academia.